Tisotumab vedotin in 2L/3L recurrent or metastatic cervical cancer: subsequent therapy data from ENGOT-CX12/GOG-3057/INNOVATV 301
Wölber, L. Sánchez, L. M. Vergote, I. Fujiwara, K. Angelergues, A. Zikán, M. Jordan, S. Lee, J. Y. Barraclough, L. Maluf, F. C.
Wölber, L.
Sánchez, L. M.
Vergote, I.
Fujiwara, K.
Angelergues, A.
Zikán, M.
Jordan, S.
Lee, J. Y.
Barraclough, L.
Maluf, F. C.
Citations
Altmetric:
Abstract
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Wölber L, Sánchez LM, Vergote I, Fujiwara K, Angelergues A, Zikán M, et al. Tisotumab vedotin in 2L/3L recurrent or metastatic cervical cancer: subsequent therapy data from ENGOT-CX12/GOG-3057/INNOVATV 301. Anticancer Research. 2025 DEC;45(12).